Top 5 Canadian Small Cap Performers of 2018

The Canadian small cap stocks we have identified have the highest YTD returns of all Canadian stocks with market caps between $250M and $2B

SmallCapPower | June 25, 2018: The year 2018 has been an interesting one for Canadian stocks. The explosive rise and fall of marijuana and blockchain stocks has drawn significant attention from all kinds of investors. As well, the actions of the Trump administration have had a wide-ranging effect on companies from the gold sector to food processing. The Canadian small cap stocks on our list today have thrived in this uncertain market, with an average YTD return of 115%. By contrast, the TSX has remained flat, the TSX-V has declined 11%, and the NYSE has eased 3%.

HLS Therapeutics Inc. (TSXV:HLS) – $9.70
Drug Retailers

HLS Therapeutics acquires, distributes, and markets drugs focused on the central nervous and cardiovascular systems. It currently markets Clozaril, which treats schizophrenia, and Absorica, which treats Acne. Two more products are in pre-filing for Canada.

  • Market Cap: $265.1M
  • 1 Month Total Return: 4.3%
  • 3 Month Total Return: -17.4%
  • YTD Total Return: 304.2%
  • 52 Week Total Return: 297.5%

iAnthus Capital Holdings Inc. (CSE:IAN) – $7.66

iAnthus Capital Holdings is a cannabis-focused company operating ~275,000 sq. ft. of cultivation and 39 dispensaries across six U.S. states. The Company’s primary asset, GrowHealthy, operates a 200,000 sq. ft. facility and 30 dispensaries in Florida, out of 13 state cultivation licenses and 35 open dispensaries.

  • Market Cap: $375.5M
  • 1 Month Total Return: 57.0%
  • 3 Month Total Return: 139.4%
  • YTD Total Return: 206.4%
  • 52 Week Total Return: 156.2%

Drone Delivery Canada Corp. (TSXV:FLT) – $1.72
Aerospace & Defense

Drone Delivery Canada is a logistics services company. Based in Vaughan, Ontario, it develops cost-effective and scalable drone technology. DDC intends to target retail, grocery, postal and related industries to market its fleet of delivery drones. The Company believes this to be a disruptive technology that will be faster, easier and cheaper than traditional delivery services.

  • Market Cap: $284.0M
  • 1 Month Total Return: 3.6%
  • 3 Month Total Return: 6.8%
  • YTD Total Return: 91.1%
  • 52 Week Total Return: 91.1%

Theratechnologies Inc. (TSX:TH) – $13.29

Theratechnologies is a pharmaceuticals company focused on HIV treatment products. The Company’s stock price increased 42% over the month following the Company’s April 30 announcement where its Trogarzo product, which treats multidrug-resistant HIV-1, was approved by the FDA. Theratechnologies is also sells EGRIFTA, the only FDA-approved drug to treat HIV-associated lipohypertrophy.

  • Market Cap: $1,018.8M
  • 1 Month Total Return: -3.7%
  • 3 Month Total Return: 37.9%
  • YTD Total Return: 85.1%
  • 52 Week Total Return: 71.3%

Midas Gold Corp. (TSX:MAX) – $1.07

Midas Gold is a U.S.-based gold developer advancing its Stibnite Gold project in Idaho. An updated resource estimate was released in February 2018 outlining a total resource of 5.6M oz Au grading 1.7 g/t Au, 8.5M oz Ag grading 2.5 g/t Ag, and 2.0M lbs of antimony at 0.1% Sb. Midas is currently in the permitting process, expected to be concluded by the end of 2019. The Company expects a further three years of construction before production commences. MAX’s stock price climbed 20% following a US$38M investment by Barrick Gold (TSX:ABX).

  • Market Cap: $252.6M
  • 1 Month Total Return: -7.0%
  • 3 Month Total Return: 8.1%
  • YTD Total Return: 81.4%
  • 52 Week Total Return: 50.7%

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: